6533b870fe1ef96bd12cf24e
RESEARCH PRODUCT
The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals.
Sebastian WagnerJan L. HülsemannHans-ulrich ProkoschHarald BinderMarc HindererFrank ÜCkertMichael NeumaierStephanie NeweTill AckerBrita SedlmayrMartin BoekerCarmen Schade-brittingersubject
AdultMalemedicine.medical_specialtyDecision support systemAttitude of Health PersonnelClinical decision support systemGermanHospitals University03 medical and health sciencesYoung Adult0302 clinical medicinePhysiciansSurveys and QuestionnairesGeneticsMedicineHumans030212 general & internal medicineReimbursementAgedPharmacologybusiness.industryMiddle AgedUniversity hospitalDecision Support Systems Clinicallanguage.human_languageTest (assessment)Pharmacogenetics030220 oncology & carcinogenesisPharmacogenomicsFamily medicinelanguageMolecular MedicineFemalebusinessdescription
Aim: The aim of this study was to assess the physicians’ attitude, their knowledge and their experience in pharmacogenomic clinical decision support in German hospitals. Materials & methods: We conducted an online survey to address physicians of 13 different medical specialties across eight German university hospitals. In total, 564 returned questionnaires were analyzed. Results: The remaining knowledge gap, the uncertainty of test reimbursement and the physicians’ lack of awareness of existing pharmacogenomic clinical decision support systems (CDSS) are the major barriers for implementing pharmacogenomic CDSS into German hospitals. Furthermore, pharmacogenomic CDSS are most effective in the form of real-time decision support for internists. Conclusion: Physicians in German hospitals require additional education of both genetics and pharmacogenomics. They need to be provided with access to relevant pharmacogenomic CDSS.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-06-09 | Pharmacogenomics |